Biotechnology
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., Sept. 30, 2025. Mike Blake | Reuters Pfizer on Monday said it filed a second lawsuit against Novo Nordisk and Metsera, alleging that the Danish drugmaker’s attempt to outbid Pfizer to acquire the obesity biotech is […]
Read More
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied. From fresh competition to new uses, the market is quickly vaulting into a new stage of […]
Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]
Read More
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar
Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster […]
Read More
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
Merck on Thursday reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its cancer immunotherapy Keytruda. The drugmaker also narrowed its full-year profit outlook to reflect lower estimated tariff costs, among other factors. Sales of Keytruda topped $8 billion for the first time in a quarter, rising 10% from the […]
Read More
FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs
U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference alongside U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, discussing administration plans to lower drug costs, at the Department of Health and Human Services in Washington, D.C., U.S., Oct. […]
Read More
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly and Walmart on Wednesday said they have teamed up to expand access to the drugmaker’s weight loss drug Zepbound, allowing U.S. patients to get vials […]
Read More
CVS beats estimates, hikes guidance as insurance business improves
Signage for a CVS pharmacy in Takoma Park, Maryland, US, on Wednesday, July 9, 2025. Al Drago | Bloomberg | Getty Images CVS Health on Wednesday reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. Still, shares of CVS fell […]
Read More
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
Eli Lilly and Nvidia are partnering to build what they call the pharmaceutical industry’s “most powerful” supercomputer and so-called AI factory to help accelerate drug discovery and development across the sector, the companies announced Tuesday. It’s the latest stride by Nvidia and the pharmaceutical industry to harness AI to help shorten the time it takes […]
Read More
Trump announces efforts to expand access to IVF drugs
U.S. President Donald Trump delivers remarks before signing an executive order on expanding access to IVF at his Mar-a-Lago resort on Feb. 18, 2025 in Palm Beach, Florida. Joe Raedle | Getty Images President Donald Trump on Thursday announced two new efforts to expand the availability of in vitro fertilization, the first concrete step from his […]
Read More